adairАллергология и Иммунология в ПедиатрииAllergology and Immunology in Paediatrics2500-11752712-7958Ассоциация детских аллергологов и иммунологов России10.53529/2500-1175-2024-2-18-25adair-143Research ArticleОБЗОРREVIEWНовые возможности аллерген-специфической иммунотерапии в отношении индукции противовирусного иммунитета у пациентов с бронхиальной астмойNew possibilities of allergen-specific immunotherapy in relation to the induction of antiviral immunity in patients with bronchial asthmahttps://orcid.org/0000-0002-7964-8867МаксимоваА. В.MaksimovaA. V.

Максимова Анна Владимировна — врач аллерголог-иммунолог, педиатр, к. м. н., доцент кафедры клинической иммунологии, аллергологии и адаптологии факультета непрерывного медицинского образования медицинского института РУДН им. Патриса Лумумбы; ведущий специалист ИАКИ.

117198, Москва, ул. Миклухо-Маклая, 6; Москва, ул. Малая Бронная, 20, стр. 1

Anna V. Maksimova - allergist-immunologist, pediatrician, candidate of medical sciences, Associate Professor of the Department of Clinical Immunology, Allergology and Adaptology, Faculty of Continuing Medical Education, Medical Institute, Patrice Lumumba Peoples’ Friendship University of Russia; Leading specialist of the Institute of Allergy and Clinical Immunology LLC (IACI).

117198, Moscow, st. Miklouho-Maclay, 6; Moscow, st. Malaya Bronnaya, 20/1

minaeva.a.v@mail.ruРоссийский университет дружбы народов им. Патриса Лумумбы; ООО «Институт аллергологии и клинической иммунологии» (ИАКИ)РоссияPatrice Lumumba Peoples’ Friendship University of Russia; Institute of Allergy and Clinical Immunology LLC (IACI)Russian Federation202424062024021825Copyright © Максимова А.В., 20242024Максимова А.В.Maksimova A.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://adair.elpub.ru/jour/article/view/143Актуальность

Актуальность. В обзоре рассмотрены современные представления о иммуномодулирующем эффекте аллерген-специфической иммунотерапии в отношении повышения резистентности к инфекционным патогенам. Изложенная информация позволит клиницистам более осознанно подходить к процессу планирования терапии бронхиальной астмы, рассматривая аллерген-специфическую иммунотерапию не только как инструмент патогенетического лечения причинно-значимой сенсибилизации, но и как инструмент иммуномодулирующей терапии в отношении респираторных вирусных инфекций.

Цель работы

Цель работы: систематизация накопленного опыта с целью предоставления информации для практикующего врача.

Relevance

Relevance. The review examines modern ideas about the immunomodulatory effect of allergen-specific immunotherapy in relation to increasing resistance to infectious pathogens. The information presented will allow clinicians to take a more conscious approach to the process of planning therapy for bronchial asthma, considering allergen-specific immunotherapy not only as a tool for pathogenetic treatment of causally significant sensitization, but also as a tool for immunomodulatory therapy against respiratory viral infections.

Purpose of the work

Purpose of the work: systematization of accumulated experience in order to provide information for the practicing physician.

бронхиальная астмааллерген-специфическая иммунотерапияIL-6IL-33ИФН-βвирусная инфекцияbronchial asthmaallergen-specific immunotherapyIL-6IL-33IFN-βviral infectionReferencesPapadopoulos NG, Psarras S, Manoussakis E, Saxoni-Papageorgiou P. The role of respiratory viruses in the origin and exacerbations of asthma. Curr Opin Allergy Clin Immunol. 2003; 3 (1): 39–44. https://doi.org/10.1097/00130832-200302000-00007.Papadopoulos NG, Psarras S, Manoussakis E, Saxoni-Papageorgiou P. The role of respiratory viruses in the origin and exacerbations of asthma. Curr Opin Allergy Clin Immunol. 2003; 3 (1): 39–44. https://doi.org/10.1097/00130832-200302000-00007.Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005; 201 (6): 937–947. https://doi.org/10.1084/jem.20041901.Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005; 201 (6): 937–947. https://doi.org/10.1084/jem.20041901.Johnston SL. IFN Therapy in Airway Disease: Is Prophylaxis a New Approach in Exacerbation Prevention? Am J Respir Crit Care Med. 2020; 201 (1): 9–11. https://doi.org/10.1164/rccm.201909-1850ED.Johnston SL. IFN Therapy in Airway Disease: Is Prophylaxis a New Approach in Exacerbation Prevention? Am J Respir Crit Care Med. 2020; 201 (1): 9–11. https://doi.org/10.1164/rccm.201909-1850ED.Валиев ТТ. Клиническое применение интерферонов: современный взгляд на вопросы эффективности и безопасности. Педиатрия. Consilium Medicum. 2020; 3: 95–104. https://doi.org/10.26442/26586630.2020.3.200286.Valiev TT. Interferon clinical use: modern view on efficacy and safety. Literature review. Pediatrics. Consilium Medicum. 2020; 3: 95–104. https://doi.org/10.26442/26586630.2020.3.200286. (In Russ.)Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002; 359 (9309): 831–834. https://doi.org/10.1016/S0140-6736(02)07953-9.Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002; 359 (9309): 831–834. https://doi.org/10.1016/S0140-6736(02)07953-9.Fortier ME, Kent S, Ashdown H, Poole S, Boksa P, Luheshi GN. The viral mimic, polyinosinic: polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol. 2004; 287 (4): R759–R766. https://doi.org/10.1152/ajpregu.00293.2004.Fortier ME, Kent S, Ashdown H, Poole S, Boksa P, Luheshi GN. The viral mimic, polyinosinic: polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol. 2004; 287 (4): R759–R766. https://doi.org/10.1152/ajpregu.00293.2004.Li Y, Xu XL, Zhao D, et al. TLR3 ligand Poly IC Attenuates Reactive Astrogliosis and Improves Recovery of Rats after Focal Cerebral Ischemia. CNS Neurosci Ther. 2015; 21 (11): 905–913. https://doi.org/10.1111/cns.12469.Li Y, Xu XL, Zhao D, et al. TLR3 ligand Poly IC Attenuates Reactive Astrogliosis and Improves Recovery of Rats after Focal Cerebral Ischemia. CNS Neurosci Ther. 2015; 21 (11): 905–913. https://doi.org/10.1111/cns.12469.Djukanović R, Harrison T, Johnston SL, et al. The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med. 2014; 190 (2): 145–154. https://doi.org/10.1164/rccm.201312-2235OC.Djukanović R, Harrison T, Johnston SL, et al. The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med. 2014; 190 (2): 145–154. https://doi.org/10.1164/rccm.201312-2235OC.Татаурщикова НС. Рациональная фармакотерапия патологии иммунитета слизистой оболочки носа у больных с аллергическим ринитом. Вестник оториноларингологии. 2013; 78 (5): 93–97.Tataurshchikova NS. Rational pharmacotherapy of the pathologically changed immune system of nasal mucosa in the patients presenting with allergic rhinitis. Russian Bulletin of Otorhinolaryngology. 2013; 78 (5): 93–97. (In Russ.)Watson A, Spalluto CM, McCrae C, et al. Dynamics of IFN-β Responses during Respiratory Viral Infection. Insights for Therapeutic Strategies. Am J Respir Crit Care Med. 2020; 201 (1): 83–94. https://doi.org/10.1164/rccm.201901-0214OC.Watson A, Spalluto CM, McCrae C, et al. Dynamics of IFN-β Responses during Respiratory Viral Infection. Insights for Therapeutic Strategies. Am J Respir Crit Care Med. 2020; 201 (1): 83–94. https://doi.org/10.1164/rccm.201901-0214OC.Frey A, Lunding LP, Ehlers JC, Weckmann M, Zissler UM, Wegmann M. More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis. Front Immunol. 2020; 11: 761. Published 2020 Apr 28. https://doi.org/10.3389/fimmu.2020.00761.Frey A, Lunding LP, Ehlers JC, Weckmann M, Zissler UM, Wegmann M. More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis. Front Immunol. 2020; 11: 761. Published 2020 Apr 28. https://doi.org/10.3389/fimmu.2020.00761.Woehlk C, von Bülow A, Kriegbaum M, Backer V, Porsbjerg C. Allergic asthma is associated with increased risk of infections requiring antibiotics. Ann Allergy Asthma Immunol. 2018; 120 (2): 169–176.e1. https://doi.org/10.1016/j.anai.2017.11.015.Woehlk C, von Bülow A, Kriegbaum M, Backer V, Porsbjerg C. Allergic asthma is associated with increased risk of infections requiring antibiotics. Ann Allergy Asthma Immunol. 2018; 120 (2): 169–176.e1. https://doi.org/10.1016/j.anai.2017.11.015.Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med. 2012; 18 (5): 684–692. Published 2012 May 4. https://doi.org/10.1038/nm.2737.Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med. 2012; 18 (5): 684–692. Published 2012 May 4. https://doi.org/10.1038/nm.2737.Jackson DJ, Makrinioti H, Rana BM, et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 2014; 190 (12): 1373–1382. https://doi.org/10.1164/rccm.201406-1039OC.Jackson DJ, Makrinioti H, Rana BM, et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 2014; 190 (12): 1373–1382. https://doi.org/10.1164/rccm.201406-1039OC.Corren J, Parnes JR, Wang L, et al. Tezepelumab in Adults with Uncontrolled Asthma [published correction appears in N Engl J Med. 2019 May 23; 380 (21): 2082]. N Engl J Med. 2017; 377 (10): 936–946. https://doi.org/10.1056/NEJMoa1704064.Corren J, Parnes JR, Wang L, et al. Tezepelumab in Adults with Uncontrolled Asthma [published correction appears in N Engl J Med. 2019 May 23; 380 (21): 2082]. N Engl J Med. 2017; 377 (10): 936–946. https://doi.org/10.1056/NEJMoa1704064.Woehlk C, Von Bülow A, Ghanizada M, Søndergaard MB, Hansen S, Porsbjerg C. Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study. Eur Respir J. 2022; 60 (5): 2200446. Published 2022 Nov 17. https://doi.org/10.1183/13993003.00446-2022.Woehlk C, Von Bülow A, Ghanizada M, Søndergaard MB, Hansen S, Porsbjerg C. Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study. Eur Respir J. 2022; 60 (5): 2200446. Published 2022 Nov 17. https://doi.org/10.1183/13993003.00446-2022.Zissler UM, Jakwerth CA, Guerth FM, et al. Early IL-10 producing B-cells and coinciding Th/Tr17 shifts during three year grass-pollen AIT. EBioMedicine. 2018; 36: 475–488. https://doi.org/10.1016/j.ebiom.2018.09.016.Zissler UM, Jakwerth CA, Guerth FM, et al. Early IL-10 producing B-cells and coinciding Th/Tr17 shifts during three year grass-pollen AIT. EBioMedicine. 2018; 36: 475–488. https://doi.org/10.1016/j.ebiom.2018.09.016.Durham SR, Shamji MH. Allergen immunotherapy: past, present and future. Nat Rev Immunol. 2023; 23 (5): 317–328. https://doi.org/10.1038/s41577-022-00786-1.Durham SR, Shamji MH. Allergen immunotherapy: past, present and future. Nat Rev Immunol. 2023; 23 (5): 317–328. https://doi.org/10.1038/s41577-022-00786-1.O’Hehir RE, Gardner LM, de Leon MP, et al. House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells. Am J Respir Crit Care Med. 2009; 180 (10): 936–947. https://doi.org/10.1164/rccm.200905-0686OC.O’Hehir RE, Gardner LM, de Leon MP, et al. House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells. Am J Respir Crit Care Med. 2009; 180 (10): 936–947. https://doi.org/10.1164/rccm.200905-0686OC.Cerps S, Sverrild A, Ramu S, et al. House dust mite sensitization and exposure affects bronchial epithelial anti-microbial response to viral stimuli in patients with asthma. Allergy. 2022; 77 (8): 2498–2508. https://doi.org/10.1111/all.15243.Cerps S, Sverrild A, Ramu S, et al. House dust mite sensitization and exposure affects bronchial epithelial anti-microbial response to viral stimuli in patients with asthma. Allergy. 2022; 77 (8): 2498–2508. https://doi.org/10.1111/all.15243.Lynch JP, Werder RB, Simpson J, et al. Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity. J Allergy Clin Immunol. 2016; 138 (5): 1326–1337. https://doi.org/10.1016/j.jaci.2016.02.039.Lynch JP, Werder RB, Simpson J, et al. Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity. J Allergy Clin Immunol. 2016; 138 (5): 1326–1337. https://doi.org/10.1016/j.jaci.2016.02.039.Durrani SR, Montville DJ, Pratt AS, et al. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol. 2012; 130 (2): 489–495. https://doi.org/10.1016/j.jaci.2012.05.023.Durrani SR, Montville DJ, Pratt AS, et al. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol. 2012; 130 (2): 489–495. https://doi.org/10.1016/j.jaci.2012.05.023.Gill MA, Bajwa G, George TA, et al. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol. 2010; 184 (11): 5999–6006. https://doi.org/10.4049/jimmunol.0901194.Gill MA, Bajwa G, George TA, et al. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol. 2010; 184 (11): 5999–6006. https://doi.org/10.4049/jimmunol.0901194.Teach SJ, Gill MA, Togias A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015; 136 (6): 1476–1485. https://doi.org/10.1016/j.jaci.2015.09.008.Teach SJ, Gill MA, Togias A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015; 136 (6): 1476–1485. https://doi.org/10.1016/j.jaci.2015.09.008.Agache I, Lau S, Akdis CA, et al. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma. Allergy. 2019; 74 (5): 855–873. https://doi.org/10.1111/all.13749.Agache I, Lau S, Akdis CA, et al. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma. Allergy. 2019; 74 (5): 855–873. https://doi.org/10.1111/all.13749.Woehlk C, Ramu S, Sverrild A, et al. Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial. Am J Respir Crit Care Med. 2023; 207 (9): 1161–1170. https://doi.org/10.1164/rccm.202209-1708OC.Woehlk C, Ramu S, Sverrild A, et al. Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial. Am J Respir Crit Care Med. 2023; 207 (9): 1161–1170. https://doi.org/10.1164/rccm.202209-1708OC.Ершов ФИ, Новохатский АС. Интерферон и его индукторы. — М.: Медицина, 1980. — 27 с.Ershov FI, Novokhatsky AS. Interferon and its inductors. — M.: Medicine, 1980. — 27 p. (In Russ.)Вавиленкова ЮА. Современные представления о системе интерферона. Вестник Смоленской государственной медицинской академии. 2012; 2: 74–82.Vavilenkova YuA. Modern ideas about the interferon system. Bulletin of the Smolensk State Medical Academy. 2012; 2: 74–82. (In Russ.)Iikura M, Suto H, Kajiwara N, et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest. 2007; 87 (10): 971–978. https://doi.org/10.1038/labinvest.3700663.Iikura M, Suto H, Kajiwara N, et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest. 2007; 87 (10): 971–978. https://doi.org/10.1038/labinvest.3700663.Silver MR, Margulis A, Wood N, Goldman SJ, Kasaian M, Chaudhary D. IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation. Inflamm Res. 2010; 59 (3): 207–218. https://doi.org/10.1007/s00011-009-0088-5.Silver MR, Margulis A, Wood N, Goldman SJ, Kasaian M, Chaudhary D. IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation. Inflamm Res. 2010; 59 (3): 207–218. https://doi.org/10.1007/s00011-009-0088-5.Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol. 2008; 121 (6): 1484–1490. https://doi.org/10.1016/j.jaci.2008.04.005.Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol. 2008; 121 (6): 1484–1490. https://doi.org/10.1016/j.jaci.2008.04.005.

The authors declare that there are no conflicts of interest present.